Order

Size
Price
Stock
Qty

Special Offers

Size
Price
Stock
Qty

Rigosertib sodium

 - ON01910 sodium  - Estybon
Axon 2950
  • Parent CAS:  592542-59-1
Purity:  99%
  • Soluble in water and DMSO
  • MF:  C21H24NNaO8S
  • MW:  473.47

Description

Rigosertib sodium is a non-ATP-competitive inhibitor of PLK1 (IC50 value of 9–10 nM) which induces mitotic arrest of tumor cells characterized by spindle abnormalities leading to their apoptosis. In vitro studies with Rigosertib sodium showed that incubation of human leukemic cells with this compound results in the inhibition of PI3K/AKT pathway, down regulation of cyclin D1, induction of NOXA and BIM and activation of JNK pathway. In vivo, Rigosertib sodium did not exhibit hematotoxicity, liver damage, or neurotoxicity, and was a potent inhibitor of tumor growth in a variety of xenograft nude mouse models.

More Information

Certificate of Analysis

Material Safety Data Sheet

Parent CAS No. 592542-59-1
Chemical Name Sodium (E)-2-(2-methoxy-5-((2,4,6-trimethoxystyrylsulfonyl)methyl)phenylamino)acetate
SMILES C1C=C(CS(=O)(=O)/C=C/C2C(OC)=CC(OC)=CC=2OC)C=C(NCC(=O)[O-])C=1OC.[Na+]
MFCD MFCD11655911
InChi InChI=1S/C21H25NO8S.Na/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25,26)13-14-5-6-18(28-2)17(9-14)22-12-21(23)24;/h5-11,22H,12-13H2,1-4H3,(H,23,24);/q;+1/p-1/b8-7+;
InChiKey VLQLUZFVFXYXQE-USRGLUTNSA-M
CID 23696523
Short Description PLK1 inhibitor

Related Products

AXON ID NAME FROM PRICE
1129 BI 2536

From $99.00

1131 GW 843682X

From $93.50

1473 BI 6727

From $99.00

1625 GSK579289A

From $121.00

1626 GSK 461364 analogue II

From $143.00

1688 GSK 461364

From $115.50

1910 MLN0905

From $104.50

2358 Mps1-IN-2

From $104.50

3918 CZS-241 hydrochloride

From $176.00

4007 NMS-1286937

From Inquiry

4192 (S)-BI 2536

From $187.00

Loading...